Effects of oral therapy with calcium and vitamin D in primary osteoporosis - PubMed (original) (raw)

Effects of oral therapy with calcium and vitamin D in primary osteoporosis

B L Riggs et al. J Clin Endocrinol Metab. 1976 Jun.

Abstract

Eighteen patients (17 women and 1 man) with primary osteoporosis were divided into two groups of 9 patients each. Group A received 2.0 to 2.5 g of calcium and 400 units of vitamin D per day orally and was studied before and after short-term (3 to 4 months) treatment; group B received 1.5 to 2.0 g of calcium per day and 50,000 units of vitamin D twice weekly and was studied before, after short-term, and after long-term (1 year) treatment. In group A there was a decrease (P is less than 0.01) in bone-resorbing surfaces (microradiography of bone biopsy samples) after short-term treatment. In group B there was a decrease (P is less than 0.01) in bone-forming and bone-resorbing surfaces after both short-tern and long-term treatment. Fasting-state (morning) serum immunoreactive parathyroid hormone (iPTH) concentrations decreased after short-term treatment (combined data of groups A and B) and after long-term treatment (group B). We conclude that the principal effect of the oral calcium and vitamin D therapy in primary osteoporosis is to decrease bone turnover. The most probable mechanism for this effect on bone is a partial inhibition of PTH secretion.

PubMed Disclaimer

Cited by

Diagnosis and management of involutional osteoporosis.
Hodsman PM. Hodsman PM. Can Fam Physician. 1979 Apr;25:467-72. Can Fam Physician. 1979. PMID: 21297728 Free PMC article.
1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.
Gallagher JC, Jerpbak CM, Jee WS, Johnson KA, DeLuca HF, Riggs BL. Gallagher JC, et al. Proc Natl Acad Sci U S A. 1982 May;79(10):3325-9. doi: 10.1073/pnas.79.10.3325. Proc Natl Acad Sci U S A. 1982. PMID: 6954482 Free PMC article.
25-Hydroxycholecalciferol in experimental osteoporosis.
Carrozzo M, Pallante R, Cantatore FP, Lo Sasso F, D'Amore M, Pipitone V. Carrozzo M, et al. Clin Rheumatol. 1985 Sep;4(3):290-3. doi: 10.1007/BF02031610. Clin Rheumatol. 1985. PMID: 4064586
Dietary calcium intake and rates of bone loss in women.
Riggs BL, Wahner HW, Melton LJ 3rd, Richelson LS, Judd HL, O'Fallon WM. Riggs BL, et al. J Clin Invest. 1987 Oct;80(4):979-82. doi: 10.1172/JCI113191. J Clin Invest. 1987. PMID: 3654981 Free PMC article.
Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss?
Riis BJ, Thomsen K, Christiansen C. Riis BJ, et al. Calcif Tissue Int. 1986 Sep;39(3):128-32. doi: 10.1007/BF02555107. Calcif Tissue Int. 1986. PMID: 3093022 Clinical Trial.

Effects of oral therapy with calcium and vitamin D in primary osteoporosis - PubMed (original) (raw)